Corpus ID: 43212414

Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.

@article{Nicolai1997DurationOA,
  title={Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.},
  author={H. von Nicolai and R. Brickl and H. Eschey and A. Greischel and G. Heinzel and E. K{\"o}nig and J. Limmer and E. Rupprecht},
  journal={Arzneimittel-Forschung},
  year={1997},
  volume={47 3},
  pages={
          247-52
        }
}
  • H. von Nicolai, R. Brickl, +5 authors E. Rupprecht
  • Published 1997
  • Medicine
  • Arzneimittel-Forschung
  • The duration of action and the pharmacokinetics of gliquidone (1-cyclohexyl-3-[[4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1, 3-dioxo-2(1H)-isochinolyl)ethyl]phenyl]-sulfonyl]-urea, AR-DF 26 SE, CAS 33342-05-1, Glurenorm, Beglynor) were investigated in 32 patients with non-insulin-dependent (type 2) diabetes mellitus over 16 h. In a single-blinded cross-over design vs. placebo, one 30 mg tablet gliquidone was administered 15 min before breakfast. Concomitant to the measurement of glucose and… CONTINUE READING
    22 Citations
    Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus
    • 29
    Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
    • 17
    Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor γ Activity: A Combined Virtual Screening and Biological Assay Approach
    • 48
    • Highly Influenced
    • PDF
    Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties.
    • P. Arnouts, D. Bolignano, +4 authors W. van Biesen
    • Medicine
    • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
    • 2014
    • 59
    • PDF
    The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes.
    • 19